As our data shown in Fig. 1, IFITM1 expression in HepG2.215 cells, which are a human liver cancer cell line that can express HBV antigen and secrete intact HBV particles, showed the same ascension as the result of HBsAg, HBeAb, and HBcAb test-positive patients, who are HBV carriers. The gene discussed is IFITM1; the disease is liver cancer.